Alzheimers Drugs Market Size, Share & Industry Analysis, By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drugs, and Others), By Application (Disease Progression and Symptom Management), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy & Drug Stores, and Online Pharmacy), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI101033

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Alzheimer’s Disease, By Key Countries/Regions
2. New Product Launches, By Key Players
3. List of Approved Drugs
4. Pipeline Analysis
5. Key Industry Developments (Mergers, Acquisitions, Partnerships etc.)
6. Recent Advances in Alzheimer's Research
7. Impact of COVID-19 on the Market
Global Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Combination Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Disease Progression
  2. Symptom Management
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy & Drug Stores
  3. Online Pharmacy
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Combination Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Disease Progression
  2. Symptom Management
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy & Drug Stores
  3. Online Pharmacy
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Combination Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Disease Progression
  2. Symptom Management
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy & Drug Stores
  3. Online Pharmacy
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Asia Pacific Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Combination Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Disease Progression
  2. Symptom Management
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy & Drug Stores
  3. Online Pharmacy
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Rest of Asia Pacific
Rest of the World Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Combination Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Disease Progression
  2. Symptom Management
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy & Drug Stores
  3. Online Pharmacy
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. EISAI CO., LTD.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. Novartis AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Biogen Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. H. Lundbeck A/S
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Otsuka Pharmaceutical Co., Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Alzheimer’s Disease, By Key Countries/Regions
2. New Product Launches, By Key Players
3. List of Approved Drugs
4. Pipeline Analysis
5. Key Industry Developments (Mergers, Acquisitions, Partnerships etc.)
6. Recent Advances in Alzheimer's Research
7. Impact of COVID-19 on the Market
Global Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Combination Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Disease Progression
  2. Symptom Management
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy & Drug Stores
  3. Online Pharmacy
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Combination Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Disease Progression
  2. Symptom Management
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy & Drug Stores
  3. Online Pharmacy
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Combination Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Disease Progression
  2. Symptom Management
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy & Drug Stores
  3. Online Pharmacy
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Asia Pacific Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Combination Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Disease Progression
  2. Symptom Management
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy & Drug Stores
  3. Online Pharmacy
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Rest of Asia Pacific
Rest of the World Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Combination Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Disease Progression
  2. Symptom Management
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy & Drug Stores
  3. Online Pharmacy
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. EISAI CO., LTD.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. Novartis AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Biogen Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. H. Lundbeck A/S
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Otsuka Pharmaceutical Co., Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Alzheimer’s Drugs Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Alzheimer’s Drugs Market Value Share (%), By Drug Class, 2025 & 2034

Figure 3: Global Alzheimer’s Drugs Market Value Share (%), By Application, 2025 & 2034

Figure 4: Global Alzheimer’s Drugs Market Value Share (%), By Distribution Channel, 2025 & 2034

Figure 5: Global Alzheimer’s Drugs Market Value (USD billion), by Region, 2025 & 2034

Figure 6: North America Alzheimer’s Drugs Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 7: North America Alzheimer’s Drugs Market Value Share (%), By Drug Class, 2025

Figure 8: North America Alzheimer’s Drugs Market Value (USD billion), By Application, 2025 & 2034

Figure 9: North America Alzheimer’s Drugs Market Value Share (%), By Application, 2025

Figure 10: North America Alzheimer’s Drugs Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 11: North America Alzheimer’s Drugs Market Value Share (%), By Distribution Channel, 2025

Figure 12: North America Alzheimer’s Drugs Market Value (USD billion), By Country, 2025 & 2034

Figure 13: North America Alzheimer’s Drugs Market Value Share (%), By Country, 2025

Figure 14: Europe Alzheimer’s Drugs Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 15: Europe Alzheimer’s Drugs Market Value Share (%), By Drug Class, 2025

Figure 16: Europe Alzheimer’s Drugs Market Value (USD billion), By Application, 2025 & 2034

Figure 17: Europe Alzheimer’s Drugs Market Value Share (%), By Application, 2025

Figure 18: Europe Alzheimer’s Drugs Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 19: Europe Alzheimer’s Drugs Market Value Share (%), By Distribution Channel, 2025

Figure 20: Europe Alzheimer’s Drugs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 21: Europe Alzheimer’s Drugs Market Value Share (%), By Country/ Sub-region, 2025

Figure 22: Asia Pacific Alzheimer’s Drugs Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 23: Asia Pacific Alzheimer’s Drugs Market Value Share (%), By Drug Class, 2025

Figure 24: Asia Pacific Alzheimer’s Drugs Market Value (USD billion), By Application, 2025 & 2034

Figure 25: Asia Pacific Alzheimer’s Drugs Market Value Share (%), By Application, 2025

Figure 26: Asia Pacific Alzheimer’s Drugs Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 27: Asia Pacific Alzheimer’s Drugs Market Value Share (%), By Distribution Channel, 2025

Figure 28: Asia Pacific Alzheimer’s Drugs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 29: Asia Pacific Alzheimer’s Drugs Market Value Share (%), By Country/ Sub-region, 2025

Figure 30: Rest of the World Alzheimer’s Drugs Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 31: Rest of the World Alzheimer’s Drugs Market Value Share (%), By Drug Class, 2025

Figure 32: Rest of the World Alzheimer’s Drugs Market Value (USD billion), By Application, 2025 & 2034

Figure 33: Rest of the World Alzheimer’s Drugs Market Value Share (%), By Application, 2025

Figure 34: Rest of the World Alzheimer’s Drugs Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 35: Rest of the World Alzheimer’s Drugs Market Value Share (%), By Distribution Channel, 2025

Figure 36: Global Alzheimer’s Drugs Market Share (%), By Company, 2025

List of Tables

Table 1: Global Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021–2034

Table 2: Global Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 3: Global Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 4: Global Alzheimer’s Drugs Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 5: North America Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 6: North America Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Application, 2021-2034

Table 7: North America Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 8: North America Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 9: Europe Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 10: Europe Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Application, 2021-2034

Table 11: Europe Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 12: Europe Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 13: Asia Pacific Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 14: Asia Pacific Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Application, 2021-2034

Table 15: Asia Pacific Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 16: Asia Pacific Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 17: Rest of the World Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 18: Rest of the World Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Application, 2021-2034

Table 19: Rest of the World Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 150

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com